{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:48:10Z","timestamp":1790102890069,"version":"4.0.1"},"reference-count":37,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>California has the largest number of people living with HIV in the United States, and in 2022, there were 4882 new diagnoses. Veterans with histories of substance use, viral hepatitis, sexually transmitted infections, and homelessness carry substantial HIV burden. Testing is essential, yet approximately 12% of Californians with HIV were undiagnosed in 2020, and 50% of veterans in care had never been tested as of 2023. HIV self-tests (HIVSTs) can mitigate stigma, confidentiality, and access barriers, and vending machines (VMs) offer private, convenient distribution. However, the use of VM-dispensed HIVST has not been evaluated for veterans or within Veterans Affairs (VA) settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We describe a Reach, Evaluation, Adoption, Implementation, and Maintenance\u2013guided pre-implementation protocol to evaluate VM-dispensed HIVSTs in Northern California VA clinics and supportive housing settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifteen VMs will stock oral-fluid HIVSTs (n=900). Program data (de-identified dispense logs), veteran electronic surveys (n=90), and qualitative interviews (n=15) will quantify reach (uptake), early effectiveness proxies (use, results, and next steps), adoption (machine\/site dispensing), implementation (stockouts, restocking interval, and costs), and maintenance (dispensing trends).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ethics approval activities (study material development and Institutional Review Board submission) began 2 months prior to the receipt of award funding (January to February 2025). Following funding, the project is planned for over a total of 18 months (12 months original project period + 6 months no-cost extension; March 2025 to August 2026). Ethics approval was obtained in August 2025. Veteran feedback was incorporated into study materials, and HIVSTs were purchased and packaged in September to November 2025. HIVSTs were added to VMs, and data collection is projected to occur from December 2025 through June 2026. Results are anticipated to be available in August 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study will generate practice-ready evidence on the feasibility, acceptability, and early behavioral impacts of VM-dispensed HIVSTs for veterans. By pairing a stigma-responsive delivery channel with pragmatic measures, findings can inform equitable scale-up across VA and community settings, guide comparative evaluations of distribution channels (VMs, mail-to-home, or clinic pick-up), and support privacy-preserving linkage strategies to confirmatory testing, HIV pre-exposure prophylaxis, and treatment. Results will address a critical evidence gap for veteran-focused HIV prevention and provide parameters for multi-site evaluations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/84317","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:00:11Z","timestamp":1767625211000},"page":"e84317-e84317","source":"Crossref","is-referenced-by-count":2,"title":["Use of Vending Machines to Deliver Oral Rapid HIV Self-Tests to Veterans: Protocol for a Pilot Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-3012","authenticated-orcid":false,"given":"Tessa","family":"Rife-Pennington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-6678","authenticated-orcid":false,"given":"Michael P","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9221-1344","authenticated-orcid":false,"given":"Wendy","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-1939","authenticated-orcid":false,"given":"Jennifer","family":"Cocohoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"R1","unstructured":"Office of Infectious Disease and HIV\/AIDS Policy, U.S. Department of Health & Human Services. EHE Overview. Mar 20, 2025. URL: https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview [Accessed 22-01-2026]"},{"key":"R2","unstructured":"U.S. Department of Veterans Affairs. Fact Sheet \u2013 Human Immunodeficiency Virus (HIV) \u2013 VA is the Largest Single Provider of HIV Care in the United States. Mar 2020. URL: https:\/\/www.hiv.va.gov\/pdf\/HIV-program-factsheet.pdf [Accessed 22-01-2026]"},{"key":"R3","unstructured":"Centers for Disease Control and Prevention. Getting Tested for HIV. Feb 11, 2025. URL: https:\/\/www.cdc.gov\/hiv\/testing\/index.html [Accessed 22-01-2026]"},{"issue":"3","key":"R4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10900-010-9233-x","article-title":"Need to improve routine HIV testing of U.S. Veterans in care: results of an Internet survey","volume":"35","author":"Valdiserri","journal-title":"J Community Health"},{"issue":"4","key":"R5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jana.2015.03.002","article-title":"Veterans and HIV screening rates: why veterans are not getting tested, a Veterans Affairs Nursing Academic Partnership (VANAP) study","volume":"26","author":"Gant-Clark","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R6","unstructured":"Division of HIV Prevention, National Center for HIV, Vital Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Self-Testing. Jun 12, 2023. URL: https:\/\/www.cdc.gov\/stophivtogether\/hiv-testing\/self-testing.html [Accessed 22-01-2026]"},{"key":"R7","unstructured":"World Health Organization. WHO recommends optimizing HIV testing services. Jul 22, 2023. URL: https:\/\/www.who.int\/news\/item\/22-07-2023-who-recommends-optimizing-hiv-testing-services [Accessed 22-01-2026]"},{"issue":"Suppl 4","key":"R8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004418","article-title":"HIV self-testing: lessons learnt and priorities for adaptation in a shifting landscape","volume":"6","author":"Gupta-Wright","journal-title":"BMJ Glob Health"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-735","article-title":"Acceptability of HIV self-testing: a systematic literature review","volume":"13","author":"Krause","journal-title":"BMC Public Health"},{"issue":"8","key":"R10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28157","article-title":"Comparing the effects of oral HIV self-testing with those of standard HIV testing for men who have sex with men (MSM): a systematic review and meta-analysis","volume":"14","author":"Vashisht","journal-title":"Cureus"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01835-z","article-title":"Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis","volume":"18","author":"Witzel","journal-title":"BMC Med"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101059","article-title":"HIV self-testing with digital supports as the new paradigm: a systematic review of global evidence (2010-2021)","volume":"39","author":"McGuire","journal-title":"EClinicalMedicine"},{"issue":"2","key":"R13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/sextrans-2023-055969","article-title":"Acceptability of digital vending machines to access STI and HIV tests in two UK cities","volume":"100","author":"Gobin","journal-title":"Sex Transm Infect"},{"issue":"7","key":"R14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103790","article-title":"Acceptability of using electronic vending machines to deliver oral rapid HIV self-testing kits: a qualitative study","volume":"9","author":"Young","journal-title":"PLoS ONE"},{"issue":"sup1","key":"R15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/09540121.2016.1146399","article-title":"Bathhouse distribution of HIV self-testing kits reaches diverse, high-risk population","volume":"28 Suppl 1","author":"Woods","journal-title":"AIDS Care"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.21037\/mhealth.2018.10.03","article-title":"Vending machines in commercial sex venues to increase HIV self-testing among men who have sex with men","volume":"4","author":"Stafylis","journal-title":"Mhealth"},{"issue":"9","key":"R17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/ajph.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","journal-title":"Am J Public Health"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11739-z","article-title":"Test@work: evaluation of workplace HIV testing for construction workers using the RE-AIM framework","volume":"21","author":"Jones","journal-title":"BMC Public Health"},{"issue":"6","key":"R19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/apc.2020.0004","article-title":"Integrating HIV pre-exposure prophylaxis into family planning care: a RE-AIM framework evaluation","volume":"34","author":"Brant","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12167-9","article-title":"Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework","volume":"21","author":"Kadiamada-Ibarra","journal-title":"BMC Public Health"},{"issue":"15","key":"R21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19159486","article-title":"Examining the implementation of conditional financial incentives using the reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) framework to improve HIV outcomes among persons living with HIV (PLWH) in Louisiana","volume":"19","author":"Chrestman","journal-title":"Int J Environ Res Public Health"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3816613\/v1","article-title":"Health provider perspectives of village health team-delivered oral HIV self-testing among men in Central Uganda: a qualitative evaluation using RE-AIM framework","author":"Nangendo","journal-title":"Res Sq"},{"key":"R23","unstructured":"University of Washington Supporting Harm Reduction Programs (sharp) team collecting demographic data at syringe services programs. Collecting Demographic Data at Syringe Services Programs. May 2023. URL: https:\/\/sites.uw.edu\/sharpta\/collecting-demographic-data [Accessed 22-01-2026]"},{"key":"R24","unstructured":"Drug Policy Alliance. Core questionnaire for supervised consumption services (SCS) evaluations. Presented at: Data Harmonization Meeting; Jan 11-12, 2018; Dallas, Texas. URL: https:\/\/astrosstudy.org\/SCS_Core_questionnaire.pdf [Accessed 22-01-2026]"},{"issue":"2","key":"R25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1521\/aeap.1996.8.2.97","volume":"8","author":"Smith","journal-title":"AIDS Educ Prev"},{"issue":"1","key":"R26","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07577-3","article-title":"Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions","volume":"22","author":"Sekhon","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"R27","first-page":"46","volume":"81","author":"Reichheld","journal-title":"Harv Bus Rev"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/8810141","article-title":"A qualitative study of HIV testing experiences and HIV self-testing perspectives among men in Northern Nigeria","volume":"2024","author":"Iliyasu","journal-title":"Nurs Res Pract"},{"issue":"2","key":"R29","doi-asserted-by":"publisher","DOI":"10.3390\/mps2020041","article-title":"Co-designing an intervention to increase HIV testing uptake with women from Indonesia at-risk of HIV: protocol for a participatory action research study","volume":"2","author":"Gray","journal-title":"Methods Protoc"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-021-00406-6","article-title":"Research led by people who use drugs: centering the expertise of lived experience","volume":"16","author":"Salazar","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-016-0116-z","article-title":"Meaningful engagement of people living with HIV who use drugs: methodology for the design of a Peer Research Associate (PRA) hiring model","volume":"13","author":"Closson","journal-title":"Harm Reduct J"},{"key":"R32","unstructured":"Rev. URL: https:\/\/www.rev.com\/ [Accessed 21-01-2026]"},{"key":"R33","unstructured":"Dill L . National Institutes of Health, Office of Disease Prevention. Engaging in Qualitative Research Methods: Opportunities for Prevention and Health Promotion. URL: https:\/\/prevention.nih.gov\/education-training\/methods-mind-gap\/engaging-qualitative-research-methods-opportunities-prevention-and-health-promotion [Accessed 22-01-2026]"},{"key":"R34","unstructured":"HHRC indicators: HIV testing. VHA HIV, Hepatitis, and Related Conditions (HHRC) Team. Jan 2024. URL: https:\/\/dvagov.sharepoint.com\/sites\/VHAOPHLDD\/Shared%20Documents\/Indicators-%20HIV%20Testing.aspx [Accessed 22-01-2026]"},{"key":"R35","unstructured":"Estimated HIV incidence and prevalence in the United States, 2018\u20132022. Centers for Disease Control and Prevention; May 2024. URL: https:\/\/www.cdc.gov\/hiv-data\/nhss\/estimated-hiv-incidence-and-prevalence.html [Accessed 22-01-2026]"},{"key":"R36","unstructured":"California HIV surveillance report \u2013 2022. California Department of Public Health, Center for Infectious Diseases, Office of AIDS; Feb 9, 2022. URL: https:\/\/www.cdph.ca.gov\/Programs\/CID\/DOA\/CDPH%20Document%20Library\/California-HIV-Surveillance-Report-2022.pdf [Accessed 22-01-2026]"},{"key":"R37","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. HIV Prevention to End the HIV Epidemic in the United States \u2013 California. URL: https:\/\/www.cdc.gov\/hivpartners\/media\/pdfs\/2025\/06\/cdc_hiv_o3pc_factsheet_california_2025-508.pdf [Accessed 22-01-2026]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:18:27Z","timestamp":1782843507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":37,"URL":"https:\/\/doi.org\/10.2196\/84317","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"v15i3e84317"}}